234 related articles for article (PubMed ID: 19538883)
1. [Biological characteristics of highly tumorigenic CD44+CD133+ subpopulation of laryngeal carcinoma cells].
Yu D; Jin CS; Chen O; Wen LJ; Gao LF
Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):99-103. PubMed ID: 19538883
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications of BMI-1 in cancer stem cells of laryngeal carcinoma.
Yu D; Liu Y; Yang J; Jin C; Zhao X; Cheng J; Liu X; Qi X
Cell Biochem Biophys; 2015 Jan; 71(1):261-9. PubMed ID: 25241082
[TBL] [Abstract][Full Text] [Related]
3. Biological characteristics of a cell subpopulation in tongue squamous cell carcinoma.
Sun Y; Han J; Lu Y; Yang X; Fan M
Oral Dis; 2012 Mar; 18(2):169-77. PubMed ID: 22023137
[TBL] [Abstract][Full Text] [Related]
4. Bmi-1 is essential for the oncogenic potential in CD133(+) human laryngeal cancer cells.
Wei X; He J; Wang J; Yang X; Ma B
Tumour Biol; 2015 Nov; 36(11):8931-42. PubMed ID: 26081615
[TBL] [Abstract][Full Text] [Related]
5. BMI1'S maintenance of the proliferative capacity of laryngeal cancer stem cells.
Chen H; Zhou L; Dou T; Wan G; Tang H; Tian J
Head Neck; 2011 Aug; 33(8):1115-25. PubMed ID: 21755556
[TBL] [Abstract][Full Text] [Related]
6. CD44 is of functional importance for colorectal cancer stem cells.
Du L; Wang H; He L; Zhang J; Ni B; Wang X; Jin H; Cahuzac N; Mehrpour M; Lu Y; Chen Q
Clin Cancer Res; 2008 Nov; 14(21):6751-60. PubMed ID: 18980968
[TBL] [Abstract][Full Text] [Related]
7. Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.
Leung EL; Fiscus RR; Tung JW; Tin VP; Cheng LC; Sihoe AD; Fink LM; Ma Y; Wong MP
PLoS One; 2010 Nov; 5(11):e14062. PubMed ID: 21124918
[TBL] [Abstract][Full Text] [Related]
8. [Investigation of CD133 as putative marker of tumor-initiating cell in laryngeal carcinoma].
Wei XD; Zhou L; Cheng L; Tian J
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Sep; 42(9):692-6. PubMed ID: 18051573
[TBL] [Abstract][Full Text] [Related]
9. CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors.
Rocco A; Liguori E; Pirozzi G; Tirino V; Compare D; Franco R; Tatangelo F; Palaia R; D'Armiento FP; Pollastrone G; Affuso A; Bottazzi EC; Masone S; Persico G; Nardone G
J Cell Physiol; 2012 Jun; 227(6):2686-93. PubMed ID: 21898409
[TBL] [Abstract][Full Text] [Related]
10. [Carcinogenicity study of CD133(+)CD44(+) laryngeal cancer stem cells and identification of related microRNAs].
Li Y; Zhou XH; Chen ZH; Dai LL; Cui CX; Wu HL; Wei QY; Fan KM; Xu YL
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jul; 54(7):529-533. PubMed ID: 31315361
[No Abstract] [Full Text] [Related]
11. Clinicopathologic significance of putative stem cell marker, CD44 and CD133, in human gastric carcinoma.
Chen S; Hou JH; Feng XY; Zhang XS; Zhou ZW; Yun JP; Chen YB; Cai MY
J Surg Oncol; 2013 Jun; 107(8):799-806. PubMed ID: 23609373
[TBL] [Abstract][Full Text] [Related]
12. Expression of the potential cancer stem cell markers CD133 and CD44 in medullary thyroid carcinoma: A ten-year follow-up and prognostic analysis.
Bi Y; Meng Y; Wu H; Cui Q; Luo Y; Xue X
J Surg Oncol; 2016 Feb; 113(2):144-51. PubMed ID: 26799258
[TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of cancer stem like cells in human glioblastoma cell lines.
Qiang L; Yang Y; Ma YJ; Chen FH; Zhang LB; Liu W; Qi Q; Lu N; Tao L; Wang XT; You QD; Guo QL
Cancer Lett; 2009 Jun; 279(1):13-21. PubMed ID: 19232461
[TBL] [Abstract][Full Text] [Related]
14. Role of CD44(high)/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer.
Zhou JY; Chen M; Ma L; Wang X; Chen YG; Liu SL
Oncotarget; 2016 Feb; 7(7):7657-66. PubMed ID: 26840024
[TBL] [Abstract][Full Text] [Related]
15. Bmi1 marks intermediate precursors during differentiation of human brain tumor initiating cells.
Venugopal C; Li N; Wang X; Manoranjan B; Hawkins C; Gunnarsson T; Hollenberg R; Klurfan P; Murty N; Kwiecien J; Farrokhyar F; Provias JP; Wynder C; Singh SK
Stem Cell Res; 2012 Mar; 8(2):141-53. PubMed ID: 22265735
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma.
Zhu Z; Hao X; Yan M; Yao M; Ge C; Gu J; Li J
Int J Cancer; 2010 May; 126(9):2067-78. PubMed ID: 19711346
[TBL] [Abstract][Full Text] [Related]
17. Expression of cancer stem cell markers and their correlation with pathogenesis in vascular tumors.
Lan J; Huang B; Liu R; Ju X; Zhou Y; Jiang J; Liang W; Shen Y; Li F; Pang L
Int J Clin Exp Pathol; 2015; 8(10):12621-33. PubMed ID: 26722452
[TBL] [Abstract][Full Text] [Related]
18. Detection of CD133, Bmi-1, and ABCG2 in ameloblastic tumors.
Kumamoto H; Ohki K
J Oral Pathol Med; 2010 Jan; 39(1):87-93. PubMed ID: 19659474
[TBL] [Abstract][Full Text] [Related]
19. [Experimental investigation of CD133 as a putative marker of tumor-initiating cell in laryngeal carcinoma].
Wei XD; Zhou L; Cheng L; Tian J
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2006 Dec; 41(12):940-4. PubMed ID: 17345710
[TBL] [Abstract][Full Text] [Related]
20. [Sorting of CD133(+) subset cells in human gastric cancer and the identification of their tumor initiating cell-like properties].
Lu RQ; Wu JG; Zhou GC; Jiang HG; Yu JW; Jiang BJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Feb; 15(2):174-9. PubMed ID: 22368028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
